A CASE-CONTROL STUDY OF HEMATOLOGICAL ANALYSIS ON DIABETES AND COVID-19 SEVERITY
Main Article Content
Keywords:
Design Retrospective, High Glucose, Morbidity Mortality, Neutrophil-Lymphocyte Ratio, Pandemic SARS-CoV-2Abstract
This study investigates the relationship between diabetes comorbidity and COVID-19 severity in Muhammadiyah Palembang Hospital, focusing on hematological parameters as potential predictors of disease progression. Utilizing a case-control design with 61 respondents, demographic data, COVID-19 severity classifications, and hematological profiles were analyzed. Results reveal a prevalence rate of diabetes mellitus among COVID-19 patients at 32.8%, with diabetic individuals experiencing higher rates of moderate clinical complications. Hematological analysis demonstrates variations in parameters such as hemoglobin levels, platelet counts, and neutrophil-to-lymphocyte ratio between diabetic and non-diabetic COVID-19 patients. These findings underscore the importance of tailored interventions for diabetic individuals infected with COVID-19 and highlight the potential of hematological parameters in predicting disease severity. The study suggests the need for larger-scale, multicenter research to validate findings and inform evidence-based clinical practice in managing COVID-19 patients with comorbid diabetes mellitus.
Article Details
References
Abumayyaleh, M. et al. Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry. Front Endocrinol (Lausanne) 14, (2023).
Albreht, T. Challenges to Global Health Emerging from the COVID-19 Pandemic. Sustainability 15, 7633 (2023).
Atwah, B. A. Y. et al. Susceptibility of Diabetic Patients to COVID-19 Infections: Clinico-Hematological and Complications Analysis. Vaccines (Basel) 11, 561 (2023).
Aulia, S. D., Djannatun, T. & Arifandi, F. Correlation between Lymphocyte Level and Mortality Rate of Covid-19 Patients in Ummi Bogor Hospital and Its Review according to Islamic View. Junior Medical Journal 1, 114–121 (2022).
Aziziyan, F. et al. Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami. Inflammopharmacology 31, 1029–1052 (2023).
Cariou, B. et al. Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative. Diabetologia 65, 1436–1449 (2022).
Embaby, A. M. et al. Clinical utility of haematological inflammatory biomarkers in predicting 30‐day mortality in hospitalised adult patients with COVID‐19. Br J Haematol 200, 708–716 (2022).
Floyd, J. S. et al. Association Between Diabetes Severity and Risks of COVID-19 Infection and Outcomes. J Gen Intern Med 38, 1484–1492 (2023).
Fukushima, T. et al. Clinical significance of prediabetes, undiagnosed diabetes and diagnosed diabetes on critical outcomes in COVID‐19: Integrative analysis from the Japan COVID‐19 task force. Diabetes Obes Metab 25, 144–155 (2022).
Garini, A. Perbandingan Hasil Hitung Jumlah Trombosit secara Otomatik pada Darah yang Ditambahkan Antikoagulan NA2EDTA 10% dengan K2EDTA VACUTAINER. JPP (Jurnal Kesehatan Poltekkes Palembang) 1, 75–78 (2012).
Hamaway, S., Nwokoma, U. N., Goldberg, M. E., Salifu, M. O. & Boursiquot, R. Impact of diabetes on COVID-19 patient health outcomes in a vulnerable racial minority community. PLoS One 18, (2023).
Kala, M. et al. A Cross-Sectional Comparative Characterization of Hematological Changes in Patients with COVID-19 Infection, Non-COVID Influenza-like Illnesses and Healthy Controls. Viruses 15, 134 (2022).
Kania, M. et al. Diabetes as a risk factor of death in hospitalized COVID-19 patients – an analysis of a National Hospitalization Database from Poland, 2020. Front Endocrinol (Lausanne) 14, (2023).
Kusumawati, M. et al. The effect of diabetes mellitus on COVID-19 mortality among patients in a tertiary-level hospital in Bandung, Indonesia. PLoS One 18, e0286797–e0286797 (2023).
Li, R. et al. Global Diabetes Prevalence in COVID-19 Patients and Contribution to COVID-19– Related Severity and Mortality: A Systematic Review and Meta-analysis. Diabetes Care 46, 890–897 (2023).
Liu, J. et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med 18, 1–12 (2020).
Moisă, E., Dutu, M., Corneci, D., Grintescu, I. & Negoita, S. Hematological Parameters and Procalcitonin as Discriminants between Bacterial Pneumonia-Induced Sepsis and Viral Sepsis Secondary to COVID-19: A Retrospective Single-Center Analysis. Int J Mol Sci 24, 5146 (2023).
Novida, H. et al. Factors associated with disease severity of COVID-19 in patients with type 2 diabetes mellitus. Biomed Rep 18, (2022).
Pelle, M. C., Zaffina, I., Provenzano, M., Moirano, G. & Arturi, F. COVID-19 and diabetes—Two giants colliding: From pathophysiology to management. Front Endocrinol (Lausanne) 13, (2022).
Prasthio, R., Yohannes, Y. & Devella, S. Penggunaan fitur HOG dan HSV untuk klasifikasi citra sel darah putih. Jurnal Algoritme 2, 120–132 (2022).
Rahmawati, C., Aini, A. & Ramadanti, R. Pengaruh Dosis Antikoagulan EDTA 10% dan Natrium Sitrat 3, 8% Pada Pemeriksaan Laju Endap Darah. Jurnal Penelitian dan Kajian Ilmiah Kesehatan Politeknik Medica Farma Husada Mataram 5, 79–85 (2019).
Roham, P. H. & Sharma, S. Dissecting the Interrelationship between COVID-19 and Diabetes Mellitus. Adv Biol e2300107–e2300107 (2023) doi:10.1002/adbi.202300107.
Russell, C. D., Lone, N. I. & Baillie, J. K. Comorbidities, multimorbidity and COVID-19. Nat Med 29, 334–343 (2023).
Schlesinger, S. et al. Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis. Diabetologia 66, 1–18 (2023).
World Health Organization. COVID-19 Clinical Management: Living Guidance, 25 January 2021. (2021).
World Health Organization. Haemoglobin Concentrations for the Diagnosis off Anaemia and Assessment of Severity. (2011).
Yonekawa, A. & Shimono, N. Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron (B.1.1.529). Biology (Basel) 11, 400 (2022).
Zhang, J., Zhang, J. & Tao, Z. Effect of Comorbid Diabetes on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type or Delta Variant of SARS-CoV-2. Front Endocrinol (Lausanne) 13, (2022).
Zhao, T. et al. When type II diabetes mellitus meets COVID‐19—Identification of the shared gene signatures and biological mechanism between the two diseases. Eur J Clin Invest 53, (2023).
Article Sidebar
Download this PDF file
pdfPublished:
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.